Tag:
Stephen Simes
Latest Headlines
Latest Headlines
BioSante axes 25% of workforce after big miss in female libido gel trials
BioSante Pharmaceuticals ( $BPAX ) alerted investors this morning to its plan to move forward after the colossal failure of its late-stage trials for its female libido gel last month. To save cash, the
Oral contraceptive a success in Phase II
Shares of BioSante Pharmaceuticals surged 14 percent this morning after news hit that a mid-stage trial of its oral contraceptive--Pill-Plus--produced positive data with indications of increased sex
